{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:52:47Z","timestamp":1784735567615,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T00:00:00Z","timestamp":1466380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s13318-016-0354-1","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T10:56:51Z","timestamp":1466420211000},"page":"407-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril\/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects"],"prefix":"10.1007","volume":"42","author":[{"given":"Mizuki","family":"Akahori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-9397","authenticated-orcid":false,"given":"Surya","family":"Ayalasomayajula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Langenickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangadhar","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.068536","author":"J Shi","year":"2016","unstructured":"Shi J, Wang X, Nguyen J, Wu AH, Bleske BE, Zhu HJ. Sacubitril is selectively activated by carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation. Drug Metab Dispos. 2016;. doi:\n                        10.1124\/dmd.115.068536\n                        \n                    .","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"354_CR2","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.ddstr.2013.11.002","volume":"9","author":"TH Langenickel","year":"2012","unstructured":"Langenickel TH, Dole WP. Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure. Drug Discov Today Ther Strateg. 2012;9(4):e131\u20139.","journal-title":"Drug Discov Today Ther Strateg."},{"issue":"11","key":"354_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993\u20131004.","journal-title":"N Engl J Med"},{"issue":"4","key":"354_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.113.02002","volume":"63","author":"K Kario","year":"2014","unstructured":"Kario K, Sun N, Chiang FT, Supasyndh O, Baek SH, Inubushi-Molessa A, et al. Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study. Hypertension. 2014;63(4):698\u2013705.","journal-title":"Hypertension"},{"issue":"4","key":"354_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/0091270009343932","volume":"50","author":"J Gu","year":"2010","unstructured":"Gu J, Noe A, Chandra P, Al-Fayoumi S, Ligueros-Saylan M, Sarangapani R, et al. Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol. 2010;50(4):401\u201314.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"354_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2165\/00003088-200645100-00001","volume":"45","author":"ML Chen","year":"2006","unstructured":"Chen ML. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2006;45(10):957\u201364.","journal-title":"Clin Pharmacokinet"},{"issue":"13","key":"354_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.107.704023","volume":"118","author":"JA Johnson","year":"2008","unstructured":"Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation. 2008;118(13):1383\u201393.","journal-title":"Circulation"},{"issue":"9","key":"354_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/0091270003256065","volume":"43","author":"TD Bjornsson","year":"2003","unstructured":"Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, et al. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol. 2003;43(9):943\u201367.","journal-title":"J Clin Pharmacol"},{"key":"354_CR9","doi-asserted-by":"publisher","unstructured":"Han Y, Ayalasomayajula S, Pan W, Yang F, Yuan Y, Langenickel T, et al. Pharmacokinetics, safety and tolerability of sacubitril\/valsartan (LCZ696) after single-dose administration in healthy Chinese subjects. Eur J Drug Metab Pharmacokinet. 2016. doi:\n                        10.1007\/s13318-016-0328-3\n                        \n                    .","DOI":"10.1007\/s13318-016-0328-3"},{"issue":"2","key":"354_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/phar.1194","volume":"33","author":"SC Laizure","year":"2013","unstructured":"Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB, et al. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 2013;33(2):210\u201322.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"354_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/bcp.12667","volume":"80","author":"EK Tarkiainen","year":"2015","unstructured":"Tarkiainen EK, Tornio A, Holmberg MT, Launiainen T, Neuvonen PJ, Backman JT, et al. Effect of carboxylesterase 1 c.428G>A single nucleotide variation on the pharmacokinetics of quinapril and enalapril. Br J Clin Pharmacol. 2015;80(5):1131\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"354_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00228-012-1315-5","volume":"69","author":"Y Suzaki","year":"2013","unstructured":"Suzaki Y, Uemura N, Takada M, Ohyama T, Itohda A, Morimoto T, et al. The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans. Eur J Clin Pharmacol. 2013;69(1):21\u201330.","journal-title":"Eur J Clin Pharmacol"},{"key":"354_CR13","unstructured":"Du Y, Chandra P, Alshare Q, Jordaan P, Langenickel T, Pal P, et al. An open-label, single dose study to investigate the absorption, distribution, metabolism, and elimination of [14C]-LCZ696 and its metabolites in healthy male subjects. AAPS annual meeting and exposition, San Antonio; 2013, pp 10\u201314."},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/jbb.1000043","volume":"2","author":"G Sunkara","year":"2010","unstructured":"Sunkara G, Thang-Dittman C, Yeh C, Kawashita H, Koseki N, Fukui Y. Assessment of ethnic differences in the pharmacokinetics and pharmacodynamics of valsartan. J Bioequiv Availab. 2010;2:6.","journal-title":"J Bioequiv Availab."},{"key":"354_CR15","doi-asserted-by":"publisher","unstructured":"Ayalasomayajula S, Langenickel TH, Chandra P, Wolfson ED, Albrecht D, Zhou W, et al. Effect of food on the oral bioavailability of the angiotensin receptor Neprilysin inhibitor sacubitril\/valsartan (LCZ696) in healthy subjects. Int J Clinic Pharmacol Therap. 2016;54. doi:\n                        10.5414\/CP202604","DOI":"10.5414\/CP202604"},{"issue":"6","key":"354_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/cpdd.131","volume":"3","author":"G Sunkara","year":"2014","unstructured":"Sunkara G, Jiang X, Reynolds C, Serra D, Zhang Y, Ligueros-Saylan M, et al. Effect of food on the oral bioavailability of amlodipine\/valsartan and amlodipine\/valsartan\/hydrochlorothiazide fixed dose combination tablets in healthy subjects. Clin Pharm Drug Dev. 2014;3(6):487\u201392.","journal-title":"Clin Pharm Drug Dev."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-016-0354-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0354-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T05:40:32Z","timestamp":1494308432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-016-0354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,20]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s13318-016-0354-1","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,20]]}}}